177 related articles for article (PubMed ID: 16527887)
1. Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.
Landgren O; Engels EA; Caporaso NE; Gridley G; Mellemkjaer L; Hemminki K; Linet MS; Goldin LR
Blood; 2006 Jul; 108(1):292-6. PubMed ID: 16527887
[TBL] [Abstract][Full Text] [Related]
2. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.
Landgren O; Linet MS; McMaster ML; Gridley G; Hemminki K; Goldin LR
Int J Cancer; 2006 Jun; 118(12):3095-8. PubMed ID: 16395700
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?
Elbæk MV; Sørensen AL; Hasselbalch HC
Leuk Lymphoma; 2016 Aug; 57(8):1793-9. PubMed ID: 26879691
[TBL] [Abstract][Full Text] [Related]
4. Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia.
Landgren O; Gridley G; Check D; Caporaso NE; Morris Brown L
Br J Haematol; 2007 Dec; 139(5):791-8. PubMed ID: 17941950
[TBL] [Abstract][Full Text] [Related]
5. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.
Goldin LR; Pfeiffer RM; Li X; Hemminki K
Blood; 2004 Sep; 104(6):1850-4. PubMed ID: 15161669
[TBL] [Abstract][Full Text] [Related]
6. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
Strati P; Caligaris-Cappio F
Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.
Landgren O; Engels EA; Pfeiffer RM; Gridley G; Mellemkjaer L; Olsen JH; Kerstann KF; Wheeler W; Hemminki K; Linet MS; Goldin LR
J Natl Cancer Inst; 2006 Sep; 98(18):1321-30. PubMed ID: 16985251
[TBL] [Abstract][Full Text] [Related]
8. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia.
Landgren O; Rapkin JS; Caporaso NE; Mellemkjaer L; Gridley G; Goldin LR; Engels EA
Blood; 2007 Mar; 109(5):2198-201. PubMed ID: 17082317
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders.
Duek A; Shvidel L; Braester A; Berrebi A
Isr Med Assoc J; 2006 Dec; 8(12):828-31. PubMed ID: 17214095
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia: epidemiology and etiologic findings.
Linet MS; Cartwright RA
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):353-7. PubMed ID: 3222144
[TBL] [Abstract][Full Text] [Related]
11. The influence of pregnancy on the development of autoimmunity in chronic lymphocytic leukemia.
Jønsson V; Bock JE; Hilden J; Houlston RS; Wiik A
Leuk Lymphoma; 2006 Aug; 47(8):1481-7. PubMed ID: 16966257
[TBL] [Abstract][Full Text] [Related]
12. Familial chronic lymphocytic leukemia in Israel: A disproportionate distribution among Ashkenazi Jews.
Zada M; Lerner D; Piltz Y; Perry C; Avivi I; Herishanu Y
Eur J Haematol; 2017 Jul; 99(1):51-55. PubMed ID: 28370385
[TBL] [Abstract][Full Text] [Related]
13. Established and suggested exposures on CLL/SLL etiology: Results from the CLL-MCC-Spain study.
Benavente Y; Casabonne D; Costas L; Robles C; Alonso E; de la Banda E; Gonzalez-Barca E; Marcos-Gragera R; Llorca J; Tardón A; Monleon JJ; Aymerich M; Campo E; Gimeno-Vázquez E; Castaño-Vinyals G; Aragonés N; Pollán M; Kogevinas M; de Sanjosé S
Cancer Epidemiol; 2018 Feb; 52():106-111. PubMed ID: 29289901
[TBL] [Abstract][Full Text] [Related]
14. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
Kristinsson SY; Koshiol J; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
J Natl Cancer Inst; 2010 Apr; 102(8):557-67. PubMed ID: 20181958
[TBL] [Abstract][Full Text] [Related]
15. Genetic predisposition of autoimmune disease and B-cell chronic lymphocytic leukemia (B-CLL).
Shirai T
Tohoku J Exp Med; 1994 May; 173(1):133-40. PubMed ID: 7528945
[TBL] [Abstract][Full Text] [Related]
16. Occupational solvent exposure and adult chronic lymphocytic leukemia: No risk in a population-based case-control study in four Nordic countries.
Talibov M; Auvinen A; Weiderpass E; Hansen J; Martinsen JI; Kjaerheim K; Tryggvadottir L; Pukkala E
Int J Cancer; 2017 Sep; 141(6):1140-1147. PubMed ID: 28571111
[TBL] [Abstract][Full Text] [Related]
17. Night shift work and chronic lymphocytic leukemia in the MCC-Spain case-control study.
Costas L; Benavente Y; Olmedo-Requena R; Casabonne D; Robles C; Gonzalez-Barca EM; de la Banda E; Alonso E; Aymerich M; Tardón A; Marcos-Gragera R; Gimeno-Vázquez E; Gómez-Acebo I; Papantoniou K; Castaño-Vinyals G; Aragonés N; Pollán M; Kogevinas M; de Sanjosé S
Int J Cancer; 2016 Nov; 139(9):1994-2000. PubMed ID: 27416551
[TBL] [Abstract][Full Text] [Related]
18. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
[TBL] [Abstract][Full Text] [Related]
19. Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms.
Sørensen AL; Hasselbalch HC
Leuk Res; 2016 Feb; 41():27-35. PubMed ID: 26718091
[TBL] [Abstract][Full Text] [Related]
20. Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.
Capalbo S; Callea V; Musolino C; Guglielmo P; D'Arena G; Fragasso A; Battista C; Giustolisi R; Brugiatelli M; Liso V
Int J Hematol; 2004 May; 79(4):354-7. PubMed ID: 15218964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
